Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets. 1983

C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq

Various 5-substituted-2'-deoxyuridines (dUrd), including 5-ethyl,5-propyl-, 5-trifluoromethyl-, 5-hydroxymethyl-, 5-formyl-, 5-vinyl-, (E)-5-(2-chlorovinyl)-, (E)-5-(2-bromovinyl)-, 5-fluoro-, 5-chloro-, 5-bromo-, 5-iodo-, 5-cyano-, 5-thiocyano-, 5-nitro- and 5-amino-dUrd, were shown to be effective substrates for the thymidine (dThd) phosphorylase isolated from human blood platelets. Some of dUrd analogs, i.e. the highly potent and selective antiherpes agent (E)-5-(2-bromovinyl)-dUrd, were degraded more rapidly than the natural substrates, dUrd and dThd. All dUrd analogs were also readily catabolised by intact human blood platelets. The potent inhibitors of thymidine phosphorylase, 6-amino-thymine and 6-amino-5-bromo-uracil, strongly inhibited the phosphorolysis of (E)-5-(2-bromovinyl)-dUrd by both purified enzyme and intact platelets.

UI MeSH Term Description Entries
D010430 Pentosyltransferases Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D001976 Bromouracil 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms. 5-Bromouracil,Bromuracil,5 Bromouracil
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003857 Deoxyuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. (beta 1-(2-Deoxyribopyranosyl))thymidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013939 Thymidine Phosphorylase An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine. PD-ECGF,Platelet-Derived Endothelial Cell Growth Factor,Gliostatin,Platelet Derived Endothelial Cell Growth Factor
D013941 Thymine One of four constituent bases of DNA. 5-Methyluracil,5 Methyluracil
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
January 2005, Medicinal research reviews,
C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
May 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology,
C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
August 1980, Journal of medicinal chemistry,
C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
August 2005, Pest management science,
C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
April 1990, Biochemical Society transactions,
C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
November 1996, Mutation research,
C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
November 1979, Biochemical pharmacology,
C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
June 1988, Journal of chromatography,
C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
May 1982, Antiviral research,
C Desgranges, and G Razaka, and M Rabaud, and H Bricaud, and J Balzarini, and E De Clercq
June 1989, Methods and findings in experimental and clinical pharmacology,
Copied contents to your clipboard!